Fundraising Fox
RheumaFinder
Founded 2023 · 12 employees on LinkedIn · 2 known investors
Find your way into RheumaFinder
Sign up to see every warm intro you have to RheumaFinder
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RheumaFinder team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RheumaFinder is an AI-powered application that analyzes CT images to detect structural bone lesions in the sacroiliac joints, intended to support radiologists in identifying patients with rheumatic disease. The software operates as a cloud-native add-on to existing PACS systems for opportunistic detection of joint damage in medical imaging studies.
Founders & leadership
RheumaFinder was founded in 2023 by Nicolaas Fosselle.
Investors · 2
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed-participationFeb 2024
Novalis Biotech Acceleration Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through RheumaFinder went on to found or lead other companies.
In the news
Frequently asked questions
- What does RheumaFinder do?
- RheumaFinder is an AI-powered application that analyzes CT images to detect structural bone lesions in the sacroiliac joints, intended to support radiologists in identifying patients with rheumatic disease. The software operates as a cloud-native add-on to existing PACS systems for opportunistic detection of joint damage in medical imaging studies.
- Who founded RheumaFinder?
- RheumaFinder was founded by Nicolaas Fosselle in 2023.
- Who are RheumaFinder's investors?
- RheumaFinder's investors include Novalis Biotech.